February 28, 2018
2 min read

Young patients with primary aldosteronism may avoid adrenal vein sampling

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Young adult patients with a typical clinical presentation of primary aldosteronism can be spared invasive and expensive adrenal vein sampling and expect similar outcomes by using CT imaging to diagnosis disease subtype, according to findings from a retrospective study conducted in Japan.

“The number of centers with successful [adrenal vein sampling] programs is limited due to the degree of technical expertise required, the invasive nature of the test and its high cost,” Mitsuhide Naruse, MD, PhD, of the department of endocrinology and metabolism at Kyoto Medical Center in Kyoto, Japan, and colleagues wrote in the study background. “Therefore, alternative diagnostic methods that obviate the necessity of [adrenal vein sampling] without sacrificing accuracy are needed.”

Naruse and colleagues analyzed data from 358 patients with primary aldosteronism with hypokalemia, elevated aldosterone and unilateral disease on CT imaging, who went on to undergo successful adrenal vein sampling (AVS), using data from the Japan Primary Aldosteronism Study between 2006 and 2016. Researchers compared the concordance of diagnosis between CT imaging and AVS findings stratified by age (< 35 years, 35 to 40 years, 40 years) and considered surgical outcomes to assess the accuracy of CT imaging findings among patients in which AVS indicated bilateral aldosteronism.

Researchers observed a concordance of diagnosis between CT imaging and AVS in 90% of patients younger than 35 years, in 79% of patients aged 35 to 40 years and in 69% of patients aged at least 40 years, suggesting a reduction in sensitivity of CT imaging in patients aged at least 40 years with hypokalemia and elevated plasma aldosterone concentration (P for trend < .01).

Additionally, researchers did not observe cases of contralateral unilateral hyperaldosteronism on AVS when compared against CT imaging in patients younger than 40 years, whereas 2% of patients aged at least 40 years showed contralateral unilateral hyperaldosteronism by AVS vs. CT imaging.

Within the cohort, 11 young adult patients showed discordance between CT imaging and AVS; among those, the three patients younger than 35 years showed surgical benefit. The same benefit was shown in only three of eight patients aged 35 to 40 years due to a lack of surgical outcome data.

The diagnostic accuracy of CT findings was 100% in patients younger than 35 years and 87% in patients aged 35 to 40 years, according to researchers.

“Our present study with a larger cohort than previous studies provided further evidence to support the recent suggestion from the Endocrine Society guideline on bypassing AVS in a subgroup of patients aged < 35 years who have spontaneous hypokalemia, aldosterone excess and unilateral adrenal disease on CT,” the researchers wrote. “In contrast, patients aged 35 to 40 years have the possibility of being spared AVS, but further validation is needed to provide conclusive evidence. The clinical relevance of our study was to clarify the subgroup that can avoid AVS before proceeding to unilateral adrenalectomy.” – by Regina Schaffer

Disclosures: The authors report no relevant financial disclosures.